NASDAQ:SCYX - SCYNEXIS News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.32 +0.04 (+3.13 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$1.32
Today's Range$1.2701 - $1.35
52-Week Range$0.35 - $2.15
Volume486,703 shs
Average Volume2.74 million shs
Market Capitalization$63.32 million
P/E Ratio-1.31
Dividend YieldN/A
Beta2.28

Headlines

SCYNEXIS (NASDAQ SCYX) News Headlines

Source:
DateHeadline
SCYNEXIS Inc (SCYX) Short Interest Up 27.7% in JanuarySCYNEXIS Inc (SCYX) Short Interest Up 27.7% in January
www.americanbankingnews.com - February 13 at 4:06 AM
Scynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation - Seeking AlphaScynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation - Seeking Alpha
seekingalpha.com - February 11 at 8:26 AM
SCYNEXIS Inc (SCYX) Given Consensus Rating of "Buy" by AnalystsSCYNEXIS Inc (SCYX) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - February 4 at 1:34 AM
SCYNEXIS Inc.SCYNEXIS Inc.
www.barrons.com - February 1 at 8:20 AM
AVITA Turns Heads, SENS Eversense Is "MRI Safe", SCYX Jumps 100% On FURI Data - NasdaqAVITA Turns Heads, SENS' Eversense Is "MRI Safe", SCYX Jumps 100% On FURI Data - Nasdaq
www.nasdaq.com - January 31 at 6:36 PM
U.S. STOCKS ON THE MOVE-Facebook, GE, DowDuPont, UPS, Intel, Scynexis - NasdaqU.S. STOCKS ON THE MOVE-Facebook, GE, DowDuPont, UPS, Intel, Scynexis - Nasdaq
www.nasdaq.com - January 31 at 6:36 PM
U.S. STOCKS ON THE MOVE-GE, Tesla, Facebook, DowDuPont, UPS - NasdaqU.S. STOCKS ON THE MOVE-GE, Tesla, Facebook, DowDuPont, UPS - Nasdaq
www.nasdaq.com - January 31 at 6:36 PM
SCYNEXIS up 26% after hours on positive ibrexafungerp dataSCYNEXIS up 26% after hours on positive ibrexafungerp data
seekingalpha.com - January 30 at 7:07 PM
SCYNEXIS Announces Positive Interim Results from Phase 3 Open-Label FURI Study, Showing Oral Ibrexafungerps Ability to Treat Refractory Fungal Infections and to Provide an Alternative to Long-Term IV TherapiesSCYNEXIS Announces Positive Interim Results from Phase 3 Open-Label FURI Study, Showing Oral Ibrexafungerp's Ability to Treat Refractory Fungal Infections and to Provide an Alternative to Long-Term IV Therapies
finance.yahoo.com - January 30 at 7:07 PM
Form 3 SCYNEXIS INC For: Jan 21 Filed by: ANIDO ARMANDO - StreetInsider.comForm 3 SCYNEXIS INC For: Jan 21 Filed by: ANIDO ARMANDO - StreetInsider.com
www.streetinsider.com - January 25 at 6:15 PM
Does SCYNEXIS, Inc.’s (NASDAQ:SCYX) CEO Salary Reflect Performance?Does SCYNEXIS, Inc.’s (NASDAQ:SCYX) CEO Salary Reflect Performance?
finance.yahoo.com - January 21 at 6:02 PM
Tuesday 1/15 Insider Buying Report: SCYXTuesday 1/15 Insider Buying Report: SCYX
www.nasdaq.com - January 15 at 6:11 PM
SCYNEXIS Provides Year-end Update and Outlines Plans for 2019 - PRNewswireSCYNEXIS Provides Year-end Update and Outlines Plans for 2019 - PRNewswire
www.prnewswire.com - January 5 at 8:14 AM
SCYNEXIS, Inc.SCYNEXIS, Inc.
www.streetinsider.com - November 14 at 8:13 AM
SCYNEXIS beats by $0.15, misses on revenueSCYNEXIS beats by $0.15, misses on revenue
seekingalpha.com - November 13 at 5:14 PM
Scynexis: 3Q Earnings SnapshotScynexis: 3Q Earnings Snapshot
finance.yahoo.com - November 13 at 5:14 PM
SCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company UpdateSCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - November 13 at 5:14 PM
Scynexis (SCYX) Reports Q3 Loss, Tops Revenue EstimatesScynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 13 at 5:14 PM
Will Scynexis (SCYX) Report Negative Earnings Next Week? What You Should KnowWill Scynexis (SCYX) Report Negative Earnings Next Week? What You Should Know
www.zacks.com - October 31 at 8:15 AM
SCYNEXIS Announces FDA Agreement with Company-Proposed Phase 3 Vulvovaginal Candidiasis Program for Oral IbrexafungerpSCYNEXIS Announces FDA Agreement with Company-Proposed Phase 3 Vulvovaginal Candidiasis Program for Oral Ibrexafungerp
finance.yahoo.com - October 23 at 5:08 PM
SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida ...SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida ...
www.prnewswire.com - October 17 at 5:01 PM
SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida auris Infections (CARES)SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida auris Infections (CARES)
finance.yahoo.com - October 15 at 5:09 PM
SCYNEXIS Supports AMR Challenge and Fungal Disease Awareness WeekSCYNEXIS Supports AMR Challenge and Fungal Disease Awareness Week
finance.yahoo.com - October 1 at 4:59 PM
SCYNEXIS to Present an Overview of the Companys Pipeline at IDWeek 2018SCYNEXIS to Present an Overview of the Company's Pipeline at IDWeek 2018
finance.yahoo.com - September 26 at 8:20 AM
SCYNEXIS, Inc. to Present at Upcoming Investor ConferencesSCYNEXIS, Inc. to Present at Upcoming Investor Conferences
finance.yahoo.com - September 25 at 8:12 AM
Who Owns SCYNEXIS Inc (NASDAQ:SCYX)?Who Owns SCYNEXIS Inc (NASDAQ:SCYX)?
finance.yahoo.com - September 18 at 5:01 PM
SCYNEXIS, Inc. to Participate in Upcoming Investor ConferencesSCYNEXIS, Inc. to Participate in Upcoming Investor Conferences
finance.yahoo.com - August 29 at 8:23 AM
SCYNEXIS misses by $0.06, misses on revenueSCYNEXIS misses by $0.06, misses on revenue
seekingalpha.com - August 10 at 8:15 AM
Scynexis (SCYX) Reports Q2 Loss, Lags Revenue EstimatesScynexis (SCYX) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 8:15 AM
Scynexis: 2Q Earnings SnapshotScynexis: 2Q Earnings Snapshot
finance.yahoo.com - August 9 at 6:08 PM
SCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company UpdateSCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - August 9 at 6:08 PM
The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
finance.yahoo.com - July 18 at 4:53 PM
Week Ahead In Pharmaceuticals - 7 Stocks To WatchWeek Ahead In Pharmaceuticals - 7 Stocks To Watch
www.nasdaq.com - July 14 at 3:39 PM
SCYNEXIS: An Update On This ~$2 Lottery TicketSCYNEXIS: An Update On This ~$2 'Lottery Ticket'
seekingalpha.com - July 14 at 3:39 PM
Why Scynexis Stock Rose 16.4% YesterdayWhy Scynexis Stock Rose 16.4% Yesterday
finance.yahoo.com - July 12 at 4:49 PM
Biotech Analysis Central Pharma News: Pfizers Unit Separation, BioCrysts Merger Collapses, Scynexis Positive Mid-Stage ResultsBiotech Analysis Central Pharma News: Pfizer's Unit Separation, BioCryst's Merger Collapses, Scynexis' Positive Mid-Stage Results
seekingalpha.com - July 12 at 8:15 AM
SCYNEXIS selects dose regimen for late-stage studies of antifungal SCY-078SCYNEXIS selects dose regimen for late-stage studies of antifungal SCY-078
seekingalpha.com - July 11 at 8:12 AM
Scynexis (SCYX) Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in VVCScynexis (SCYX) Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in VVC
www.streetinsider.com - July 10 at 5:00 PM
SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal CandidiasisSCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis
finance.yahoo.com - July 10 at 5:00 PM
Complimentary Technical Snapshots on Mylan and Three More Generic Drugs StocksComplimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks
finance.yahoo.com - July 2 at 8:23 AM
SCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual MeetingSCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual Meeting
finance.yahoo.com - June 27 at 8:48 AM
Scynexis, Undervalued And Filling A Critical Need In The Antifungal SpaceScynexis, Undervalued And Filling A Critical Need In The Antifungal Space
seekingalpha.com - June 26 at 5:20 PM
Form 8-K SCYNEXIS INC For: Jun 14Form 8-K SCYNEXIS INC For: Jun 14
www.streetinsider.com - June 22 at 5:45 PM
SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018
finance.yahoo.com - June 14 at 8:18 AM
SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - June 11 at 5:14 PM
Your Daily Pharma Scoop: Scynexis Moves Up, Proteostasis Disappoints Investors, Cellectar ZoomsYour Daily Pharma Scoop: Scynexis Moves Up, Proteostasis Disappoints Investors, Cellectar Zooms
seekingalpha.com - June 11 at 8:12 AM
SCYNEXIS announces publication of early-stage SCY-078 data; shares up 2% premarketSCYNEXIS announces publication of early-stage SCY-078 data; shares up 2% premarket
seekingalpha.com - June 6 at 5:31 PM
SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - May 24 at 5:46 PM
Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs StocksFree Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks
finance.yahoo.com - May 24 at 8:15 AM
SCYNEXIS to Participate in a Panel at the 2018 BIO International ConventionSCYNEXIS to Participate in a Panel at the 2018 BIO International Convention
finance.yahoo.com - May 23 at 5:40 PM
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel